Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review

Document Sample
Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					        Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis
                                      Review
        Reference Code: GDPH62115FSA                                                                                          Publication Date: AUG 2012

          Route de la Corniche 4                             Phone              +41 21 6534535                  Revenue          0.18 (million EUR)
          Epalinges, Waadt                                   Fax                +41 21 6532473                  Net Profit       -10.54 (million EUR)
          1066                                               Website            www.mymetics.com                Employees        9
                                                                                MYMX     [Over          The                      Pharmaceuticals           &
          Switzerland                                        Exchange                                           Industry
                                                                                Counter]                                         Healthcare

       Company Overview
       Mymetics Corporation (Mimetics) is a development stage biotechnology company formerly known as Hippocampe S.A. It carries
       out the research and development of virosomes and mucosal vaccines for HIV, malaria, respiratory syncytial virus (RSV) and
       Influenza. The vaccines being developed by the company acts as a first line of defense against the viruses entering the blood
       stream and do not contain any live attenuated or killed pathogens.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Mymetics Corporation, SWOT Analysis
         Ronald Kempers                      Chief Financial Officer                  Strengths                              Weaknesses
         Grant Pickering                     Chief Executive Officer
                                                                                      Sturdy Research and                    History of Losses
         Dr. Christopher S Henney            Chairman                                 Development Activities
                                                                                                                             Dependence on Third Parties
         Christian Rochet                    Director
                                                                                      Innovative Approach of
         Thomas Staehelin                    Director                                 Development
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData
                                                                                      Opportunities                          Threats
       Share Data
         Mymetics Corporation                                                         Focus on Large HIV Treatment Tightening of FDA’s Regulatory
                                                                                      Market                       Oversight
        Share Price (EUR) as on 03-Aug-                                  0.04
        2012                                                                          Emerging Markets                       Intense Competition
        EPS (EUR)                                                       -0.05
        Market Cap (million EUR)                                           12        Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million EUR)                                     43
        Shares Outstanding (million)                                     295
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 11, 2012         Mymetics Reports Q1 2012 Results
                                                                                      Apr 11, 2012         Mymetics Appoints Grant Pickering As CEO
                                                                                      Mar 29, 2012         Mymetics Reports 2011 Results
                                                                                      Nov 14, 2011         Mymetics Reports Q3 2011 Results
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Mymetics Corporation (MYMX) - Financial and Strategic SWOT                                                                     Reference Code: GDPH62115FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Mymetics Corporation - Key Facts ..................................................................................................................................................... 5
       Mymetics Corporation - Key Employees............................................................................................................................................. 6
       Mymetics Corporation - Key Employee Biographies .......................................................................................................................... 7
       Mymetics Corporation - Major Products and Services ........................................................................................................................ 8
       Mymetics Corporation - Pharmaceutical Pipeline Products Data ....................................................................................................... 9
          Mymetics Corporation, Pipeline Products by Therapy Area ............................................................................................................ 9
          Mymetics Corporation, Pipeline Products by Development Phase ............................................................................................... 10
       Mymetics Corporation - History ........................................................................................................................................................ 11
       Mymetics Corporation - Company Statement ................................................................................................................................... 13
       Mymetics Corporation - Locations And Subsidiaries ........................................................................................................................ 14
          Head Office ................................................................................................................................................................................... 14
          Other Locations & Subsidiaries ..................................................................................................................................................... 14
       Section 2 – Company Analysis ......................................................................................................................................................... 15
       Mymetics Corporation - Business Description .................................................................................................................................. 15
       Mymetics Corporation - Corporate Strategy ..................................................................................................................................... 16
       Mymetics Corporation - SWOT Analysis .......................................................................................................................................... 17
          SWOT Analysis - Overview........................................................................................................................................................... 17
          Mymetics Corporation - Strengths ................................................................................................................................................ 17
             Strength - Sturdy Research and Development Activities ........................................................................................................... 17
             Strength - Innovative Approach of Development ....................................................................................................................... 17
             Strength - Intellectual Property .................................................................................................................................................. 17
          Mymetics Corporation - Weaknesses ........................................................................................................................................... 17
             Weakness - History of Losses ................................................................................................................................................... 17
             Weakness - Dependence on Third Parties ................................................................................................................................ 18
          Mymetics Corporation - Opportunities .......................................................................................................................................... 18
             Opportunity - Focus on Large HIV Treatment Market................................................................................................................ 18
             Opportunity - Emerging Markets ................................
				
DOCUMENT INFO
Description: Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Mymetics Corporation (Mimetics), formerly known as Hippocampe S.A., is a development stage biot
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.